Health
Results: 385-396 of 6716

Rapid Medical™ Surpasses 1,000 Cases With DRIVEWIRE™ 24 in North America and Expands Into Europe With MDR Approval

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

AliveDx announces U.S. Food and Drug Administration (FDA) 510(k) submission for its MosaiQ AiPlex® Vasculitis (VAS) assay.

New Analysis Shows Corrected T1 (cT1) Is the Most Appropriate Diagnosis and Monitoring Tool for Widespread Adoption of Resmetirom Treatment in the United States
